Dr. Sulaiman Al Habib Medical Services Group

4013 · Tadawul · SAR

SAR 225.20Change from previous close: −0.57%Absolute change: −SAR 1.30

Close · October 1, 2026

At a glance

Revenue growth
+22.38%
2025 vs 2024
Net income growth
+3.72%
2025 vs 2024
Net margin
17.5%
2024: 20.7%

Financial data

Amounts in millions of SAR; per-share values in SAR; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue13,70711,2009,5088,3117,250
Cost of revenue9,5137,4716,2555,5784,934
Gross profit4,1943,7303,2542,7332,316
Selling, general and administrative1,5751,3731,1581,032850
Operating income2,6192,3562,0961,7001,466
EBIT2,6192,3562,0961,7001,466
EBITDA3,1932,7112,3581,9601,728
Interest expense33916370.149.437.9
Pre-tax income2,5192,4132,1701,7971,501
Income tax27.642.968.5108114
Net income2,4012,3152,0461,6511,377
Net income to common shareholders2,4012,3152,0461,6511,377
Basic EPS6.866.625.854.723.93
Diluted EPS6.866.625.854.723.93
Average shares (basic)350350350350350
Average shares (diluted)350350350350350
Dividend per share4.834.774.323.482.80